EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Selected Proteins Involved in the Neuropathology of ASD as the Candidates for Fluid Biomarkers

Piotr Rutkowski, Adrianna Romanowicz, Jan Mroczko, Monika Gudowska-Sawczuk iD, Barbara Mroczko iD

Molecules · 03.06.2026 · 31 (11) · 1936

DOI: 10.3390/molecules31111936 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 03.06.2026. Verfasst von Piotr Rutkowski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health Center for Children and Adolescents, University Children Clinical Hospital, 15-274 Bialystok, Poland. Hauptthemen laut MEDLINE: Biomarkers, Autism Spectrum Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Białystok, Medical University of Bialystok, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder (ASD) is classified as a neurodevelopmental disorder with an increasingly high incidence rate. Increasing awareness, changing diagnostic criteria and social attitudes, as well as financial considerations, will affect the prevalence of diagnosis. The symptoms of ASD vary widely, making it difficult to detect. It represents a spectrum of alterations ranging from mild indications to severe impairments and diagnosis is based on a very rigorous behavioral assessment. Nevertheless, certain neuropathological changes are common, although the background of this disorder remains still unknown. Therefore, some research aimed at better understanding the pathology of the neurological alterations in ASD, as well as the possibilities for early diagnosis and treatment of this disorder, is urgently needed. This review summarizes the current evidence on some selected proteins such as tau protein, NFL, and BDNF as well as IGF-1 that appear to be the best protein candidates for better understanding the causes of autism, as well as for use as fluid biomarkers in the diagnosis and monitoring of ASD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersAutism Spectrum DisorderHumanstau ProteinsBrain-Derived Neurotrophic FactorInsulin-Like Growth Factor IAnimals

Stichwörter der Autor:innen

ASDBDNFIGF-1NFLautismtau protein

Substanzen

Biomarkerstau ProteinsBrain-Derived Neurotrophic FactorInsulin-Like Growth Factor I

Autor:innen und Institutionen

  • Mental Health Center for Children and Adolescents, University Children Clinical Hospital, 15-274 Bialystok, Poland.
  • Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
  • Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.

ORCID-Profile: Monika Gudowska-Sawczuk, Barbara Mroczko

Förderung

  • Medical University of Białystok
  • Medical University of Bialystok, Poland

Zitieren

APA

Rutkowski, P., Romanowicz, A., Mroczko, J., Gudowska-Sawczuk, M., & Mroczko, B. (2026). Selected Proteins Involved in the Neuropathology of ASD as the Candidates for Fluid Biomarkers. Molecules, 31(11), 1936. https://doi.org/10.3390/molecules31111936

Vancouver

Rutkowski P, Romanowicz A, Mroczko J, Gudowska-Sawczuk M, Mroczko B. Selected Proteins Involved in the Neuropathology of ASD as the Candidates for Fluid Biomarkers. Molecules. 2026;31(11):1936. doi:10.3390/molecules31111936

BibTeX
@article{Rutkowski2026,
  author = {Rutkowski, Piotr and Romanowicz, Adrianna and Mroczko, Jan and Gudowska-Sawczuk, Monika and Mroczko, Barbara},
  title = {Selected Proteins Involved in the Neuropathology of ASD as the Candidates for Fluid Biomarkers},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {11},
  pages = {1936},
  doi = {10.3390/molecules31111936}
}
Kostenlos starten →